OVERVIEW | NEWS | MULTIMEDIA | RESEARCH |
Biofrontera AG Company Summary |
|
|
|
COMPANY DATA |
|||||||||
 |
Homepage | www.biofrontera.com/ |
 |
||
Key Developments: Biofrontera AG
 |
Biofrontera AG; Patient Treatment In Phase III Study With BF-200 ALA For Actinic
Keratosis Completed OCT 7, 2008 18:59 - Article Views: 202 Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- | |
| ||
118 COMPANY PROFILE VIEWS |
||||
|
|
|
Site Search
| ENGLISH All Languages |
Companies in the News
ABN Newswire on iPhone/iPad
|
| Download from Apple |
Mobile Video TV
|
||
|
||
